Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $573K 983 sh | Apr 21, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $254K 442 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $284K 488 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $282K 482 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $397K 687 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $504K 880 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $289K 500 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $589K 1,009 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $581K 1,010 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 3 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $13K 416 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $6,413 140 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $197K 340 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $139K 238 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 0 | Wren ChrisVP of Operations |  PLNHPlanet 13 Holdings Inc.Open-market sale · 10b5-1 plan | SELL | $4,521 30.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 0 | Wren ChrisVP of Operations | PLNHPlanet 13 Holdings Inc. Open-market sale · 10b5-1 plan | SELL | $384 2,500 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 50 | Baugher Joshua ScottChief Financial Officer |  AGXARGAN INCOpen-market sale | SELL | $363K 600 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 44 |  Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $2.42M 28.0K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 41 | Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $875K 10.0K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 41 | Rogers Mark NEVP & General Counsel |  AMKRAMKOR TECHNOLOGY, INC.Open-market sale | SELL | $297K 5,000 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 38 | Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $133K 1,500 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 38 | Karmiri StefaniaCorporate Secretary |  ESEAEUROSEAS LTD.Open-market sale | SELL | $18K 250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 37 | Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $976K 11.4K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 36 | Lichtman MosheDirector |  VLNValens Semiconductor Ltd.Open-market sale | SELL | $5,513 3,750 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 35 | Subotovsky SantiagoDirector |  ZMZoom Communications, Inc.Open-market sale · 10b5-1 plan | SELL | $97K 1,106 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 35 | Gline MatthewDirector, CEO |  ROIVRoivant Sciences Ltd.Open-market sale | SELL | $8.45M 289.8K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 34 | Antonoff LaurenDirector, Chief Executive Officer |  LIFLife360, Inc.Open-market sale | SELL | $123K 2,716 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 34 | Saha AnuragCHIEF ACCOUNTING OFFICER | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $1.35M 3,157 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 33 | Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $541K 6,400 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 33 | Nakamura Eileen CheighDirector |  GAB.RTGABELLI EQUITY TRUST INCOpen-market sale | SELL | $742 9,640 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 32 | Subotovsky SantiagoDirector | ZMZoom Communications, Inc. Open-market sale · 10b5-1 plan | SELL | $9,810 111 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 32 | Yaacobi TalDirector | VLNValens Semiconductor Ltd. Open-market sale | SELL | $5,513 3,750 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 32 | Subotovsky SantiagoDirector | ZMZoom Communications, Inc. Open-market sale · 10b5-1 plan | SELL | $5,365 60 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 31 | Piekos BrianChief Financial Officer |  KALVKalVista Pharmaceuticals, Inc.Open-market sale | SELL | $38K 1,862 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 31 | Subotovsky SantiagoDirector | ZMZoom Communications, Inc. Open-market sale · 10b5-1 plan | SELL | $96K 1,111 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 30 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $54K 2,686 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 29 | Swenson Christopher C.Chief Legal Officer |  NRDYNerdy Inc.Open-market sale | SELL | $65K 69.8K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 28 | Ullal JayshreeDirector, CEO and Chairperson |  ANETArista Networks, Inc.Open-market sale · 10b5-1 plan | SELL | $36.49M 229.2K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 27 | Coen Steven P.See remarks |  DNAGinkgo Bioworks Holdings, Inc.Open-market sale | SELL | $2,576 324 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 27 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $38K 1,862 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 26 | Grossman Eric FChief Legal/Admin Officer |  MSMORGAN STANLEYOpen-market sale | SELL | $1.06M 5,559 sh | Apr 20, 2026 traded Apr 20, 2026 |